Rib-X Pharma (RIBX) Cuts IPO Price from $12-$14 to $6-$7/Share
Tweet Send to a Friend
According to an amended S-1 filing with the SEC Tuesday morning, Rib-X Pharmaceuticals (Nasdaq: RIBX) now expects to price 10 million shares of common stock in the range of $6-$7 per share for its initial public offering. The company had previously expected to sell about 5.77 million common shares in the range of $12-$14 per share.
Rib-X plans to list on the NASDAQ exchange under the symbol "RIBX."
The offering is being made through Deutsche Bank, William Blair, Lazard and Needham.
Rib-X is a biopharmaceutical company developing new antibiotics to provide superior coverage, safety and convenience for the treatment of serious and life-threatening infections. The company's proprietary drug discovery platform, which is based on Nobel Prize-winning science, provides an atomic-level, three-dimensional understanding of interactions between drug candidates and their bacterial targets and enables Rib-X to systematically engineer antibiotics with enhanced characteristics.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Rib-X plans to list on the NASDAQ exchange under the symbol "RIBX."
The offering is being made through Deutsche Bank, William Blair, Lazard and Needham.
Rib-X is a biopharmaceutical company developing new antibiotics to provide superior coverage, safety and convenience for the treatment of serious and life-threatening infections. The company's proprietary drug discovery platform, which is based on Nobel Prize-winning science, provides an atomic-level, three-dimensional understanding of interactions between drug candidates and their bacterial targets and enables Rib-X to systematically engineer antibiotics with enhanced characteristics.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Evoke Pharma (EVOK) Files $24M IPO
- GDC Technology (GDCT) Files $75M IPO
- Tableau Software (DATA) IPO indicated $37-$40 after pricing at $31
Create E-mail Alert Related Categories
IPOsRelated Entities
Deutsche Bank, William Blair, Needham & Company, Lazard, S1
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
